Addiction MedsDisordersMedicationsOpioidsResearchSubstance UseDosing Buprenorphine in the Fentanyl EraAugust 3, 2026by Chris Aiken, MD2
Addiction MedsAlcoholCocaineDisordersKetamineMedicationsOpioidsResearchSubstance UseKetamine for AddictionJuly 24, 2026by Chris Aiken, MD0
Addiction MedsMedicationsOpioidsResearchSubstance UseBuprenorphine vs Naltrexone: A Large StudyJuly 15, 2026by Chris Aiken, MD0
Addiction MedsAlcoholCannabisDisordersMethamphetamineOpioidsResearchSedativesSubstance UseNew Guidelines For Substance Use DisordersJuly 12, 2026by Chris Aiken, MD2
Addiction MedsDisordersMed-PsychOpioidsResearchSubstance UseMatching Opioid MAT for Complex PatientsJuly 10, 2026by Chris Aiken, MD0
AlcoholOpioidsResearchSubstance UseBuprenorphine and Naltrexone for Impaired PhysiciansJune 17, 2026by Chris Aiken, MD0
BenzodiazepinesOpioidsResearchSubstance UseDoes Buprenorphine Block Opioid Overdose?May 27, 2026by Chris Aiken, MD0
GLP1 AgonistsOpioidsResearchSubstance UseGLP-1 Drugs and Opioid Use DisorderMay 13, 2026by Chris Aiken, MD0
AlcoholCannabisCocaineMethamphetamineOpioidsResearchSubstance UseSupplementsProbiotics Fail in Substance-Induced DepressionMarch 18, 2026by Chris Aiken, MD0
BenzodiazepinesDeprescribingGeriatric PsychiatryMedicationsOpioidsResearchSedativesTop ResearchStopping Benzos May Raise Mortality RiskDecember 1, 2023by Chris Aiken, MD0